哈尔滨三联药业股份有限公司 关于全资子公司获得政府补助的公告

Group 1 - The company received a government subsidy of 6 million yuan, which accounts for 10.23% of the latest audited net profit attributable to shareholders [1] - The subsidy is classified as a revenue-related government grant, which is defined as grants not related to assets [1] - The subsidy is expected to positively impact the company's operating performance, with an anticipated increase in total profit of 6 million yuan for the year 2026 [2] Group 2 - The company has confirmed the receipt of the subsidy as of the announcement date [1] - Relevant documents regarding the subsidy include government approval documents and payment receipts [4]